Karuna Therapeutics Inc (DELISTED) (KRTX:DL)
329.83
0.00 (0.00%)
USD |
NASDAQ |
Mar 18, 16:00
Karuna Therapeutics Research and Development Expense (TTM): 364.10M for Dec. 31, 2023
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 364.10M |
| September 30, 2023 | 347.91M |
| June 30, 2023 | 305.91M |
| March 31, 2023 | 265.91M |
| December 31, 2022 | 224.25M |
| September 30, 2022 | 203.34M |
| June 30, 2022 | 180.16M |
| March 31, 2022 | 151.82M |
| December 31, 2021 | 128.20M |
| September 30, 2021 | 98.69M |
| June 30, 2021 | 72.50M |
| Date | Value |
|---|---|
| March 31, 2021 | 59.17M |
| December 31, 2020 | 43.41M |
| September 30, 2020 | 32.82M |
| June 30, 2020 | 26.02M |
| March 31, 2020 | 21.99M |
| December 31, 2019 | 24.54M |
| September 30, 2019 | 26.26M |
| June 30, 2019 | 21.89M |
| March 31, 2019 | 17.28M |
| December 31, 2018 | 11.54M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
21.89M
Minimum
Jun 2019
364.10M
Maximum
Dec 2023
136.78M
Average
98.69M
Median
Sep 2021
Research and Development Expense (TTM) Benchmarks
| Bristol-Myers Squibb Co | 9.673B |
| RayzeBio inc (DELISTED) | -- |
| Icosavax Inc (DELISTED) | 70.04M |
| Madrigal Pharmaceuticals Inc | 272.35M |
| Theseus Pharmaceuticals Inc (DELISTED) | 47.22M |